Centene Corporation (CNC) recently unveiled that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc., has been chosen by the Illinois Department of Healthcare and Family Services (HFS) to continue providing enhanced managed care services to 77,000 dually eligible residents via a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). This program will provide comprehensive care and support across the state for individuals who qualify for both Medicare and Medicaid, including those enrolled in ...

I write for retail value investors who cannot afford to lose money but sometimes like to take a risk. I speak for free to community and school groups. I was teaching business, social/political activism, and Middle East politics to international university students in Tel Aviv b4 the pandemic hit. A college in Jerusalem hired me to teach business and American Politics beginning in the fall of 2023. I consult with startups and mid-level companies. I co-manage Goldmeier Investments LLC with my son Daniel. I fo ...

ST. LOUIS, March 17, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing Medicare and Medicaid services for dually eligible Illinoisans through a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). The D-SNP program will provi ...

Group 1 - Centene Corporation will present at the Barclays 27th Annual Global Healthcare Conference on March 12, 2025, at 2:30 p.m. EDT via webcast [1] - A replay of the webcast will be available on Centene's website under the Investors section [1] - Centene is a Fortune 500 company focused on providing integrated healthcare services to under-insured and uninsured individuals [2] Group 2 - The company offers affordable and high-quality healthcare products to over 1 in 15 individuals in the nation, including Medicaid and Medicare members [2] - Centene employs a local approach with local brands and teams to deliver cost-effective services [2] - Important information about Centene is routinely posted on its investor relations website [3]

Core Viewpoint - Centene's recent earnings report shows strong performance in adjusted EPS and revenue growth, but challenges remain with membership declines and increased operating expenses [2][3][12]. Financial Performance - Adjusted EPS for Q4 2024 was 80 cents, exceeding estimates by 63.3% and up 77.8% year over year [2]. - Total revenues reached $40.8 billion, a 3.4% increase year over year, surpassing consensus estimates by 4.8% [2]. - Full-year revenues for 2024 were $163.1 billion, a 5.9% increase from 2023, with adjusted EPS of $7.17, up 7.3% year over year [12]. Revenue Breakdown - Medicaid revenues decreased by 1% to $20.8 billion, while Medicare revenues increased by 4% to $5.5 billion [4]. - Commercial revenues grew significantly by 18% year over year to $8.7 billion [4]. - Premiums totaled $35.5 billion, rising 3.8% year over year, exceeding estimates [5]. Membership and Operational Metrics - Total membership as of Dec. 31, 2024, was 28.6 million, a 4.1% increase year over year [7]. - Health Benefits Ratio (HBR) deteriorated by 10 basis points to 89.6% [7]. - Total operating expenses increased by 2.5% to $40.6 billion, driven by higher medical costs and premium tax expenses [8]. Cash Flow and Debt - Cash and cash equivalents stood at $14.1 billion, down 18.2% from the end of 2023 [10]. - Long-term debt rose by 4% to $18.4 billion [10]. - Net cash from operations was $154 million, significantly lower than the previous year [11]. Future Guidance - For 2025, management projects premium and service revenues of $158-$160 billion, indicating a 9.3% growth from 2024 [14]. - Adjusted EPS is expected to exceed $7.25, reflecting a 1.1% increase from 2024 [14]. Market Position and Comparisons - Centene's stock has a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [17]. - In comparison, Cigna, a competitor in the same industry, reported revenues of $65.68 billion, a year-over-year increase of 28.4% [18].

Core Insights - The collaboration between Peach State Health Plan, Centene Foundation, Atlanta Housing, and the City of Atlanta aims to redevelop the Bowen Homes community to enhance access to quality housing, healthcare, and community resources [1][4] - The Centene Foundation's funding marks the first state-level deployment of its partnership with McCormack Baron Salazar, focusing on predevelopment design and local community engagement [2] - The redevelopment plan includes over 750 residential units and recreational amenities, emphasizing health, empowerment, and resilience for families in the community [3] Company Overview - Peach State Health Plan is a care management organization serving Georgians, focusing on Medicaid and under-insured populations through various health insurance solutions [5] - Centene Foundation is a private nonprofit that invests in economically challenged communities, aiming to improve health equity and address social drivers of health [6]

Group 1 - Superior HealthPlan is accepting applications for its annual grant program aimed at community-based organizations and providers in Texas, with a deadline of March 31, 2025 [1][3] - The funding focuses on addressing non-medical drivers of health, also known as social determinants of health, to support low-income neighborhoods [1][2] - Since 2020, Superior has allocated over $740,000 to community partners and providers to tackle barriers to health and wellness [2] Group 2 - In 2025, a total of $200,000 will be distributed, with ten community-based organizations and ten providers each receiving $10,000 [3] - Grant recipients must serve the Medicaid population and are required to allow a follow-up visit by December 15 to demonstrate funding outcomes [5] - All necessary documentation must be submitted by April 30, 2025, to complete the application process [5]

Core Insights - Superior HealthPlan, a managed care organization in Texas and a Centene company, collaborated with local schools to celebrate No One Eats Alone® Day, addressing social isolation among students [1][3] - The event reached 1.5 million students nationwide, with 16 schools in Texas participating in activities designed to foster a sense of belonging and community [5][1] - Beyond Differences, the nonprofit organization behind the initiative, aims to combat social isolation and promote a culture of belonging in schools [9][5] Company Overview - Superior HealthPlan was founded in 1999 and operates throughout Texas, focusing on delivering quality healthcare and community involvement [6] - The Centene Foundation, the philanthropic arm of Centene, supports projects aimed at improving health equity and addressing social determinants of health [8][7] - Beyond Differences provides free Social-Emotional Learning tools to schools, with over 10,000 institutions currently utilizing their programs [9]

ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members.Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnersh ...

Membership Growth - Year-end membership reached 28.6 million, an increase of 1.1 million members, or 4% over 2023[282] - Managed care membership increased by 1.1 million, or 4%, from December 31, 2023, to December 31, 2024, totaling 28.6 million members[302] - Medicare PDP membership increased by 50% year-over-year, while Medicare Advantage membership declined by 13%[295] Revenue Performance - Total revenues for 2024 were $163.1 billion, representing 6% growth year-over-year[282] - Total revenues for the year ended December 31, 2024, increased by 6% to $163.1 billion, driven by membership growth and Medicaid rate increases[304] - Total revenues increased by 6% to $163.1 billion in 2024, driven by a 36% increase in Commercial revenues, while Other revenues decreased by 20%[318] - Total revenues for 2024 reached $163,071 million, an increase of 5.4% from $153,999 million in 2023[402] Earnings and Profitability - Diluted earnings per share (EPS) increased to $6.31 for 2024, compared to $4.95 for 2023[282] - Adjusted diluted EPS rose to $7.17 for 2024, representing a 7% growth year-over-year[282] - Net earnings attributable to Centene Corporation for 2024 were $3,305 million, up 22.3% from $2,702 million in 2023[402] - Basic earnings per common share increased to $6.33 in 2024, compared to $4.97 in 2023, reflecting a growth of 27.3%[402] - The company reported a comprehensive earnings of $3,453 million in 2024, compared to $3,182 million in 2023, an increase of 8.5%[404] Expenses and Cost Management - SG&A expense ratio improved to 8.5% for 2024, down from 9.0% for 2023[282] - SG&A expense ratio decreased to 8.5% for the year ended December 31, 2024, from 9.0% in 2023, primarily due to the divestiture of Circle Health and lower Medicare SG&A[309] - Total impairment charges for 2024 were $13 million, significantly lower than the $529 million recorded in 2023, which included a $292 million charge related to Circle Health[310][311] Medical Claims and Liabilities - The total medical claims liability as of December 31, 2024, was $18.3 billion, an increase from $18.0 billion in 2023[370] - The company incurred $128.3 billion in medical claims related to the current year for 2024, compared to $120.7 billion in 2023[370] - Medical claims liability includes claims reported but not yet paid, estimates for claims incurred but not reported, and processing costs[435] - The Company uses actuarial methods to estimate medical claims liability, considering historical data and various relevant factors[435] Cash Flow and Financing - Operating cash flows were $154 million for 2024, a significant decrease from $8.1 billion for 2023[282] - Cash used in financing activities rose to $2.4 billion in 2024, driven by stock repurchases totaling $3.1 billion, compared to $1.6 billion in 2023[330][331] - The company has $2.2 billion remaining under its stock repurchase program as of December 31, 2024, after repurchasing 42 million shares for $3.0 billion[333] Divestitures and Acquisitions - The company divested its majority stake in Apixio in June 2023, recognizing a gain of $93 million, or $67 million after-tax[272] - The company completed several divestitures, including Operose Health and Circle Health, impacting its operational structure[296] - The Company completed the divestitures of Circle Health and Collaborative Health Systems (CHS) during 2024[416] Capital and Investments - The debt-to-capital ratio increased to 41.2% as of December 31, 2024, from 40.7% in 2023, influenced by stock repurchases and increased borrowings[338] - The company has short-term investments of $2.6 billion and long-term investments of $18.8 billion as of December 31, 2024[384] Regulatory and Compliance - The company anticipates limited reductions in Medicaid membership post-redeterminations, as most states have completed their unwinding processes by December 2024[278] - The Company reached an agreement with the federal government in 2024 to retroactively compensate for the difference in cost sharing reductions (CSRs) from 2018 to 2020[450] Accounting and Reporting - Revenue recognition is based on premiums received from states, members, and CMS, with adjustments for risk scores based on member acuity[373] - The Company estimates risk adjustment revenues based on diagnosis data submitted to CMS, recording revenues on a risk-adjusted basis[443] - The Company adopted new accounting guidance in Q4 2024 regarding segment reporting, which will enhance disclosures about significant expenses[459]